GGrantIndex
Sort

64,565 grants matching drug discovery

Reasons for poor durability of resin-dentin bonds

$644,409
David H Pashley · Augusta University · R01 · FY2012 · DE

Interactions of retroviral and host proteins guided by advanced modeling

$644,288
Monica J Roth · Rutgers Biomedical And Health Sciences · R35 · FY2023 · GM

A scalable system for high-throughput and longitudinal electrophysiology in rodent brain research

$644,241
Mattias Peter Karlsson · Spikegadgets, Llc · R44 · FY2021 · MH

Brain-penetrant GPR88 agonists as novel therapeutics for opioid abuse

$644,048
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · DA

Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symporters

$644,038
Jonathan A Javitch · Columbia University Health Sciences · R01 · FY2012 · DA

Advancing Knowledge Discovery for Postoperative Pain Management

$644,033
Tina Hernandez-Boussard · Stanford University · R01 · FY2021 · LM

Synthesis and Evaluation of Functionally Biased Opioid Analgesics

$644,021
Laura M Bohn · Scripps Florida · R01 · FY2014 · DA

Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum

$643,981
Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2021 · AI

A High-Throughput Cell-based Drug Discovery System

$643,965
Genome Data Systems, Inc. · R44 · FY2005 · DK

Positive Allosteric Modulators as PET Imaging Ligans for mGluR4

$643,961
Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2016 · NS

Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning

$643,949
Fang Zheng · University Of Kentucky · UH3 · FY2025 · NS

Structure-based inhibition of chemokine signaling in the inflamed pancreas

$643,818
Brian F Volkman · Medical College Of Wisconsin · R01 · FY2025 · DK

UCSF Paul Calabresi K12 Career Development Program in Clinical Oncology

$643,767
Emily K Bergsland · University Of California, San Francisco · K12 · FY2025 · CA

Zebrafish Lipid Metabolism Assay for Drug Screening

$643,750
Zygogen, Llc · R44 · FY2005 · DK

Discovering the essential genome of Plasmodium falciparum

$643,737
John Adams · University Of South Florida · R01 · FY2021 · AI

Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary Fibrosis

$643,499
Susanne Heynen-Genel · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2022 · HL

Discovery of SARS-CoV-2 antivirals using a replicon assay

$643,490
Stefan G Sarafianos · Emory University · R01 · FY2023 · AI

Methyltransferase Drug Discovery

$643,482
Haiching Ma · Reaction Biology Corporation · R44 · FY2010 · CA

Engineering 3D Osteosarcoma Models to Elucidate Biology and Inform Drug Discovery

$643,432
Fan Yang · Stanford University · R01 · FY2025 · CA

Selective Fyn kinase inhibitors for treatment of metabolic disease

$643,364
Benjamin M Buehrer · Zen-Bio, Inc. · R44 · FY2015 · DK

Development of an Efficient 18F labeling technology based on tetrazine trans-cyclooctene ligation

$643,360
Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Alzheimer Disease Genetic Architecture in African Americans

$643,341
Lindsay A. Farrer · Boston University Medical Campus · R01 · FY2017 · AG

Direct lateral habenula projection to a critical pain transmission circuit

$643,262
Elyssa Margolis · University Of California, San Francisco · R01 · FY2024 · NS

Movement-Responsive Cage for Simultaneous Pharmacology Studies in Minipigs

$643,229
Douglas D. Mann · Bioanalytical Systems, Inc. (Basi) · R44 · FY2007 · RR

NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS

$643,219
Georgetown University · R01 · FY2003 · CA